Product Images Tikosyn

This is a table showing the mean change in QTc (measured in msec) from baseline on Day 1 and Day 23 (Steady State) along with the mean Plasma Dofetilide concentration (measured in ng/mL). There is no additional information available.*

This text appears to be a table of medication dosages and associated p-values for a Log Rank Test with a placebo, displayed over a certain period of time measured in months. The medication is “Dofetide” and has three different dosages: 125mg bid, 250mg bid, and 500mg bid. The p-values for these dosages during the test were found to be 0.21, 0.10, and less than 0.001, respectively. The “T” letters and numbers in the last row are not clear enough to decipher their meaning.*

This appears to be a table representing a clinical trial for Dofetilide, a medication used to treat heart arrhythmias. The table includes various dosages of the medication taken twice daily (BID) and their corresponding p-values (a measure of statistical significance) as determined by a Log Rank Test. The time frame of the study is also shown as months on the bottom axis.*

This text provides instructions for administering dofetilide, a medication used to treat irregular heartbeats, while monitoring the patient's heart rate and kidney function. The dosage is determined based on the patient's creatinine clearance level, and the patient's QTc or QT interval is regularly checked to ensure that the medication is not causing adverse effects. If the patient's QTc or QT interval exceeds certain thresholds, the medication should not be used or the dosage should be adjusted.*

This text is a brief description of the distributor of a product called Pfizer Labs. It states that Pfizer Labs is a division of Pfizer Inc, located in NY, NY 10017.*

This is a statement containing information about the distribution of Pfizer Labs products by the Division of Pfizer Inc located in NY, NY 10017.*

This text is a label for Tikosyn® (dofetilide) Capsules containing 125 meg (0.125 mg) dofetilide. The label provides instructions for storing and dispensing the medication in a controlled environment. The medication should be protected from moisture and humidity and dispensed in child-resistant containers. The label suggests referring to the accompanying prescribing information for dosage and use instructions. The medication is manufactured in Ireland and distributed by Pfizer Labs, a division of Pfizer Inc located in NY, NY. Finally, the label indicates to always dispense with medication guide, has a GTIN code, and includes a LOT/EXP number.*

This is a medication guide for Tikosyn (dofetilide) capsules in the strength of 125 mcg (0.125 mg) with 40 capsules in UNIT DOSE packaging for in-institution use only. It is distributed by Pfizer Labs and is Rx-only. It contains information about storing the medication at controlled room temperature and protecting it from moisture and humidity. The dosage and use are not provided, and it advises users to refer to the accompanying prescribing information.*

This text contains instructions for storing and dispensing medication, specifically, Tikosyn® (dofetilide) Capsules. The medication should be stored at a controlled room temperature between 15-30°C, protected from moisture and humidity, and dispensed in tight, child-resistant containers. Each capsule contains 250 meg (0.25 mg) dofetlide. The prescribing information should be consulted for dosage and use. The medication is distributed by Plizer Labs, a division of Pfizer Inc, and is made in Ireland. The lot/expiry information for a specific batch is also provided.*

The text contains medical drug information, specifically about capsules of Tikosyn® containing 250mcg (0.25mg) of dofetilide for cardiac arrhythmia in different lots and batches. It also includes some unclear and unformatted text lines that could not be accurately evaluated.*

This is a medication guide for Tikosyn® dofetilide capsules. It is intended for in-institution use only and comes in a unit dose of 40 capsules. The capsules should be stored at a controlled room temperature of 15° to 30°C (59°F to 86°F) and protected from moisture and humidity. Each capsule contains 250 mg (0.25 mg) dofetilide. The prescribing information should be consulted for dosage and use information. The medication guide should always be dispensed with the product. Distributed by Prizer Labs, a division of Pfzer Inc. Made in Ireland.*

This text provides instructions for handling and storing Tikosyn capsules, which contain 500 micrograms (0.5 milligrams) of dofetilide. The capsules should be kept at a controlled room temperature between 15 and 30 degrees Celsius, and protected from moisture and humidity. They should be dispensed in tightly sealed, child-resistant containers. More detailed information about proper dosage and use can be found in the accompanying prescribing information. The capsules are made in Ireland and distributed by Pfizer Labs, a division of Pfizer Inc. The LOT and EXP numbers are not available in the provided text.*

This is a medication guide for Tikosyn (dofetilide) capsules. It is for in-institutional use only and is intended to be distributed in unit doses. Each capsule contains 500 micrograms (0.5mg) of dofetilide. The prescribing information should be consulted for dosage and usage details. The medication should be stored at a controlled room temperature and protected from moisture/humidity. The manufacturer is Pfizer Labs and the product is made in Ireland. This text includes a notice that the medication guide should always be dispensed along with the product.*